Death caused by strongyloides hyperinfection in a leprosy patient on treatment for a type II leprosy reaction

Leprosy Review

Volumn 75, Issue 4, 2004, Pages 398-403

  Leang, Bunse ^a   Lynen, Lut ^b   Tootill, Ruth ^a   Griffiths, Stephen ^c   Monchy, Didier ^d  

^a Sihanouk Hospital Center of HOPE   (Cambodia)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c Kien Khleang National Rehabilitation Center   (Cambodia)

^d INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; IVERMECTIN; STEROID;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGRANULOCYTOSIS; ARTICLE; CAMBODIA; CASE REPORT; DEATH; EARLY DIAGNOSIS; FECES ANALYSIS; HUMAN; ILEUS; IMMUNOSUPPRESSIVE TREATMENT; LAPAROTOMY; LEPROSY; LONG TERM CARE; MALE; MORTALITY; PANCYTOPENIA; PREVENTIVE MEDICINE; RARE DISEASE; REVERSAL REACTION; SEPTIC SHOCK; STRONGYLOIDES HYPERINFECTION SYNDROME; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; SUPERINFECTION; SURVIVAL; SYNDROME DELINEATION;

ADULT; ANIMALS; DISEASE PROGRESSION; FATAL OUTCOME; HUMANS; ILEUS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LEPROSTATIC AGENTS; LEPROSY; MALE; RISK ASSESSMENT; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; SUPERINFECTION;

EID: 12444311602     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis, 2001; 33: 1040-1047.
2. Shinozaki F, Takada K, Tamai T et al. [Strongyloidiasis associated with multiple myeloma in Ehime prefecture]. Kansenshogaku Zasshi, 1994; 68: 539-543.
3. Davidson RA, Fletcher RH, Chapman LE. Risk factors for strongyloidiasis. A case-control study. Arch Intern Med, 1984; 144: 321-324.
4. Tsai HC, Lee SS, Liu YC et al. Clinical manifestations of strongyloidiasis in southern Taiwan. J Microbiol Immunol Infect, 2002; 35: 29-36.
5. Mahmoud AF. State-of-the-art clinical article: Strongyloidiasis. Clin Infect Dis, 1996; 23: 949-953.
6. Graeff-Teixeira C, Leite CS, Sperhacke CL et al. Prospective study of strongyloidosis in patients with hematologic malignancies. Rev Soc Bras Med Trop, 1997; 30: 355-357.
7. Nair D. Screening for Strongyloides infection among the institutionalized mentally disabled. J Am Board Fam Pract, 2001; 14: 51-53.
8. Fisher D, McCarry F, Currie B. Strongyloidiasis in the Northern Territory. Under-recognised and under-treated? Med J Aust, 1993; 159: 88-90.
9. Karolyi Z, Eros N, Kriston R. [Cutaneous manifestations of strongyloidosis]. Orv Hetil, 1999; 140: 191-194.
10. Bannon JP, Fater M, Solit R. Intestinal ileus secondary to Strongyloides stercoralis infection: case report and review of the literature. Am Surg, 1995; 61: 377-380.
11. Boken DJ, Leoni PA, Preheim LC. Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum. Clin Infect Dis, 1993; 16: 123-126.
12. de Silva N et al. Anthelminthics. A comparative review of their clinical pharmacology. Drugs, 1997; 53: 769-788.
13. Weller PF. Strongyloidiasis. UpToDate, 1998; 7.2: 1-5.
14. Torres JR, Isturiz R, Murillo J et al. Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clin Infect Dis, 1993; 17: 900-902.
15. Nozais JP, Thellier M, Datry A, Danis M. [Disseminated strongyloidiasis]. Presse Med, 2001; 30: 813-818.
16. Gelber M, Rodrig J. [Strongyloides stercoralis hyperinfection]. Harefuah, 1996; 130: 90-92, 143.
17. Chiodini PL, Reid AJ, Wiselka MJ et al. Parenteral ivermectin in Strongyloides hyperinfection. Lancet, 2000; 355: 43-44.
18. Hagelskjaer LH. A fatal case of systemic strongyloidiasis and review of the literature. Eur J Clin Microbiol Infect Dis, 1994; 13: 1069-1074.
19. Muennig P, Pallin D, Sell RL, Chan MS. The cost-effectiveness of strategies for the treatment of intestinal parasites in immigrants. New Engl J Med, 1999; 340: 773-779.
20. Hui JY, Woo PC, Lo SS, Chan JC. Over-the-counter medication and its effects. Lancet, 2002; 359: 1120.